European Commission
Keeping tabs on pharma: Tensions rise between AstraZeneca and EU over vaccine delays and R&D innovation challenge developed to improve healthcare opportunities
January 29 by Emily UwemedimoAstraZeneca's vaccine is currently in the final stages of the approval process with the European Medicines Agency, but there are problems with supply and delivery
Boehringer Ingelheim's Johannes Schoen on How to Prepare for the Falsified Medicines Directive
February 18 by Pharmaceuticals & Biotechnology EditorIn this recent interview, Johannes Schoen, Supply Network Quality Management Anti-Counterfeitng, Boehringer Ingelheim speaks to Andrea Charles from Pharma IQ, following facilitating the "Anti-Counterf...
The Launch of Once-Daily Pill Gives New Hope for Epilepsy Patients
September 28 by Pharmaceuticals & Biotechnology EditorJapanese pharmaceutical giant Eisai has launched a new epilepsy drug in Europe following approval by the European Commission. Discovered and developed in the United Kingdom, Fycompa® (perampa...
DIA Presents 10 Global Awards
June 19 by Andrea CharlesThe DIA Global Award winners were announced this morning at the opening plenary session of DIA 2011. Recognised for a range of achievements the winners were:Distinguished Career Award...
A Year in European Variations Regulation
December 20 by Pharma IQVariations, regardless of their simplicity, are still required to pass through a complex regulatory process for the products to remain authorised for sale on the market. The process is essential...
More Physiologically-Relevant Cellular Assays for Cardio and Neurotoxicity Testing- An Interview With Susanne Bremer-Hoffmann
April 25 by Susanne Bremer-HoffmannPharma IQ:How are you developing more physiologically-relevant cellular assays for cardio and neurotoxicity testing? Susanne Bremer-Hoffmann:In the last 3 years we have evaluated the potential of...
European Commission's Laurent Selles on Medical Device UDIs: 60 Second Interview
April 25 by Laurent SellesThe FDA Final Rule on UDIs for medical devices is expected to be published in early August. Recently, the EU Commission announced their intention to take an internationally harmonised approach and f...
Exclusive Interview: European Commission on the Implementation of the EU Cosmetics Regulation
April 25 by David HudsonIn this exclusive Pharma IQ interview, David Hudson, Spokesperson for Consumer Policy, European Commission (at the time of this interview), shares the achievements of EU Cosmetic Regulation and disc...